| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.26 | 4e-12 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | -0.19 | 9e-09 |
| mRNA | SNX-2112 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.31 | 2e-07 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.18 | 2e-07 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.17 | 2e-07 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-07 |
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 5e-07 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | -0.17 | 8e-07 |